Kim L. R. Brouwer, PharmD, PhD, is the William R. Kenan Distinguished Professor and chair of the Division of Pharmacotherapy and Experimental Therapeutics of the UNC Eshelman School of Pharmacy and a professor in the curriculum in toxicology.

Dr. Brouwer directs an NIH-funded research program focused on hepatobiliary drug disposition and development and refinement of in vitro model systems to predict in vivo hepatobiliary disposition, drug interactions, and hepatotoxicity. She is a co-inventor of B-CLEAR® (U.S. Patent No. 6,780,580), an in vitro method to assess hepatic uptake, excretion, and biliary clearance that correlates with in vivo data. This technology has been exclusively licensed from the University of North Carolina at Chapel Hill to Qualyst, Inc. Dr. Brouwer is a Qualyst founder and chairs the company’s scientific advisory board.